Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Bioorganic & Medicinal Chemistry
|
August 15, 2017
Radiosynthesis and preclinical PET evaluation of <sup>89</sup>Zr-nivolumab (BMS-936558) in healthy non-human primates
Erin L Cole, Joonyoung Kim, David J Donnelly, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 31, 2018
Mapping the central effects of (±)-ketamine and traxoprodil using pharmacological magnetic resonance imaging in awake rats
Haiying Tang, Daniel Kukral, Yu-Wen Li, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 31, 2021
Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
Stephanie Robu, Antonia Richter, Dario Gosmann, et al.
Plos One
|
November 10, 2017
Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease
Viktor Martyanov, Grace-Hyun J Kim, Wendy Hayes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2017
Evaluation of the Lysophosphatidic Acid Receptor Type 1 Radioligand <sup>11</sup>C-BMT-136088 for Lung Imaging in Rhesus Monkeys
Jean-Dominique Gallezot, Nabeel B Nabulsi, Daniel Holden, et al.
Atherosclerosis
|
April 28, 2015
The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial
Hamed Emami, Esad Vucic, Sharath Subramanian, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 20, 2009
Downregulation of 18F-FDG uptake in PET as an early pharmacodynamic effect in treatment of non-small cell lung cancer with the mTOR inhibitor everolimus
Lucia Nogová, Ronald Boellaard, Carsten Kobe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 31, 2016
RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group
Lawrence H Schwartz, Lesley Seymour, Saskia Litière, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
January 29, 2022
Evaluation of a PEGylated Fibroblast Growth Factor 21 Variant Using Novel Preclinical Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Mouse Model of Nonalcoholic Steatohepatitis
Haiying Tang, Jiahui Li, Bradley Zinker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 16, 2020
Quantification of PD-L1 Expression with <sup>18</sup>F-BMS-986192 PET/CT in Patients with Advanced-Stage Non-Small Cell Lung Cancer
Marc C Huisman, Anna-Larissa N Niemeijer, Albert D Windhorst, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Bioorganic & Medicinal Chemistry
|
August 15, 2017
Radiosynthesis and preclinical PET evaluation of <sup>89</sup>Zr-nivolumab (BMS-936558) in healthy non-human primates
Erin L Cole, Joonyoung Kim, David J Donnelly, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 31, 2018
Mapping the central effects of (±)-ketamine and traxoprodil using pharmacological magnetic resonance imaging in awake rats
Haiying Tang, Daniel Kukral, Yu-Wen Li, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 31, 2021
Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
Stephanie Robu, Antonia Richter, Dario Gosmann, et al.
Plos One
|
November 10, 2017
Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease
Viktor Martyanov, Grace-Hyun J Kim, Wendy Hayes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 3, 2017
Evaluation of the Lysophosphatidic Acid Receptor Type 1 Radioligand <sup>11</sup>C-BMT-136088 for Lung Imaging in Rhesus Monkeys
Jean-Dominique Gallezot, Nabeel B Nabulsi, Daniel Holden, et al.
Atherosclerosis
|
April 28, 2015
The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial
Hamed Emami, Esad Vucic, Sharath Subramanian, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 20, 2009
Downregulation of 18F-FDG uptake in PET as an early pharmacodynamic effect in treatment of non-small cell lung cancer with the mTOR inhibitor everolimus
Lucia Nogová, Ronald Boellaard, Carsten Kobe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 31, 2016
RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group
Lawrence H Schwartz, Lesley Seymour, Saskia Litière, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
January 29, 2022
Evaluation of a PEGylated Fibroblast Growth Factor 21 Variant Using Novel Preclinical Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Mouse Model of Nonalcoholic Steatohepatitis
Haiying Tang, Jiahui Li, Bradley Zinker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 16, 2020
Quantification of PD-L1 Expression with <sup>18</sup>F-BMS-986192 PET/CT in Patients with Advanced-Stage Non-Small Cell Lung Cancer
Marc C Huisman, Anna-Larissa N Niemeijer, Albert D Windhorst, et al.
Page
of 4